Genetic studies of drug response and side effects in the STAR*D study, part 2

J Clin Psychiatry. 2009 Sep;70(9):1323-5. doi: 10.4088/JCP.09ac05522.

Authors

Holly A Garriock¹, Steven P Hamilton

Affiliation

¹ Department of Psychiatry and Institute for Human Genetics, University of California, San Francisco, CA 94143-0984, USA.

PMID: 19818256
DOI: 10.4088/JCP.09ac05522

No abstract available

MeSH terms

Antidepressive Agents / adverse effects*
Antidepressive Agents / therapeutic use*
Citalopram / adverse effects*
Citalopram / therapeutic use*
Depressive Disorder, Major / drug therapy*
Depressive Disorder, Major / genetics*
Genetic Markers
Genetic Predisposition to Disease
Genetic Variation
Genome-Wide Association Study
Genotype
Humans
Pharmacogenetics
Phenotype
Polymorphism, Single Nucleotide / genetics
Randomized Controlled Trials as Topic / statistics & numerical data
Serotonin Plasma Membrane Transport Proteins / genetics*
Sexual Dysfunctions, Psychological / chemically induced
Suicide / psychology
Treatment Outcome

Substances

Antidepressive Agents
Genetic Markers
SLC6A4 protein, human
Serotonin Plasma Membrane Transport Proteins
Citalopram